WASHINGTON--(BUSINESS WIRE)--The November 5th Fasano Longevity Conference included a wide range of presentations, including an analysis of the mid-term elections and groundbreaking cancer research.
Washington insider, Kevin Madden, opened the Conference with his take on the mid-term elections. He was followed by Coventry Chairman, Alan Buerger, who gave an upbeat assessment of the outlook for the Life Settlement market.
The morning sessions also featured a presentation by Securis Investment Partners with their analysis of Current Investment Values in Life Settlements, and finished with an analysis by Dr. Steven Rigatti of the Different Methods of Measuring Biologic Age.
The afternoon sessions opened with a captivating presentation by Northwestern University’s Dr. Thomas Meade on his original research into ways of Disabling Cancer Cells from Metastasizing. The afternoon sessions also included Wharton School research on the Impact of Medicare Reform on Longevity, James Atkins’ Critique of Pricing in the Secondary Structured Settlement Market and an all-star panel presentation covering the Impact of New Privacy Regulations in both the U.S. and the European Union.
Said Michael Fasano, President of Fasano Associates, "We attracted 200 longevity and investment professionals this year, and the feedback has been extraordinarily positive. The presentations included a good balance of politics, investment analysis and breakthrough medical research." Fasano described his Conference as "Investor Focused."
DVDs of the Conference are available (www.fasanoassociates.com) for $495. Next year's Fasano Longevity Conference will be held on Monday, November 4, 2019, in Washington, DC.
About Fasano Associates:
Fasano Associates is a leading underwriting consulting firm serving the life, health, annuity and life settlement industries.
